CTLA4-Ig (Abatacept) for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes (TN-18)
![](https://rockymountaindiabetes.com/wp-content/uploads/2017/03/type-ii-diabetes-1024x683.jpg)
Enroll Now
Type of Study:
Type 1 Diabetes
Title of Study:
CTLA4-Ig (Abatacept) for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes (TN-18)
Study Length: Indefinite
Target Age/Sex: Any
Link: ClinicalTrials.gov